Tre administration downregulates their expressions to the levels of the control, indicating that Tre could effectively attenuate HS-induced ERS, which might be associated with the inhibition of the eif2α-CHOP signal. The gene discussed is DDIT3; the disease is amelogenesis imperfecta type 1G.